Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2006, p. 759-761, Vol. 50, No. 2
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.2.759-761.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection
David A. Kocisko,1*
Winslow S. Caughey,1
Richard E. Race,1
Grant Roper,2
Byron Caughey,1 and
John D. Morrey2
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana,1
Institute for Antiviral Research, Animal, Dairy, and Veterinary Sciences Department, Utah State University, Logan, Utah2
Received 8 September 2005/
Returned for modification 14 November 2005/
Accepted 23 November 2005
Prion diseases, including scrapie, are incurable neurodegenerative disorders. Some compounds can delay disease after a peripheral scrapie inoculation, but few are effective against advanced disease. Here, we tested multiple related porphyrins, but only Fe(III)meso-tetra(4-sulfonatophenyl)porphine injected into mouse brains after intracerebral scrapie inoculation substantially increased survival times.
* Corresponding author. Mailing address: Rocky Mountain Laboratories, 903 S. 4th Street, Hamilton, MT 59840. Phone: (406) 375-9692. Fax: (406) 363-9286. E-mail:
DKocisko{at}niaid.nih.gov.
Antimicrobial Agents and Chemotherapy, February 2006, p. 759-761, Vol. 50, No. 2
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.2.759-761.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Song, C.-H., Honmou, O., Ohsawa, N., Nakamura, K., Hamada, H., Furuoka, H., Hasebe, R., Horiuchi, M.
(2009). Effect of Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Mice Infected with Prions. J. Virol.
83: 5918-5927
[Abstract]
[Full Text]
-
Song, C.-H., Furuoka, H., Kim, C.-L., Ogino, M., Suzuki, A., Hasebe, R., Horiuchi, M.
(2008). Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. J. Gen. Virol.
89: 1533-1544
[Abstract]
[Full Text]
-
Lee, K. S., Raymond, L. D., Schoen, B., Raymond, G. J., Kett, L., Moore, R. A., Johnson, L. M., Taubner, L., Speare, J. O., Onwubiko, H. A., Baron, G. S., Caughey, W. S., Caughey, B.
(2007). Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein. J. Biol. Chem.
282: 36525-36533
[Abstract]
[Full Text]
-
Caughey, W. S., Priola, S. A., Kocisko, D. A., Raymond, L. D., Ward, A., Caughey, B.
(2007). Cyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity. Antimicrob. Agents Chemother.
51: 3887-3894
[Abstract]
[Full Text]
-
Doh-ura, K., Kuge, T., Uomoto, M., Nishizawa, K., Kawasaki, Y., Iha, M.
(2007). Prophylactic Effect of Dietary Seaweed Fucoidan against Enteral Prion Infection. Antimicrob. Agents Chemother.
51: 2274-2277
[Abstract]
[Full Text]
-
Trevitt, C. R, Collinge, J.
(2006). A systematic review of prion therapeutics in experimental models. Brain
129: 2241-2265
[Abstract]
[Full Text]